Marcie A. Goldstein

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 69,000,000 shares of Class A common stock of Maravai LifeSciences…

Davis Polk advised the representatives of the underwriters in connection with the $112 million public offering of 2,500,000 shares of common stock of Stoke Therapeutics, Inc., which…

Davis Polk advised the sole book-running manager in connection with the $80 million initial public offering of 8,000,000 units of Consonance-HFW Acquisition Corp. Each unit consists of…

Davis Polk advised the representatives of the several underwriters in connection with the $352 million follow-on offering of 11,000,000 shares of common stock of Jamf Holding Corp. sold by…

Davis Polk advised the representatives of the several underwriters in connection with the $240 million initial public offering of 12,650,000 shares of common stock of Olema Oncology at $19…

Davis Polk advised the sole book-running manager in connection with the $172.5 million initial public offering of 17,250,000 units of Population Health Investment Co., Inc., which includes…

Davis Polk advised the underwriters in connection with the $230 million initial public offering of 23,000,000 units of Natural Order Acquisition Corp., which includes 3,000,000 units…

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14,375,000 shares of common stock of Atea Pharmaceuticals, Inc.,…

Davis Polk advised the representatives of the underwriters in connection with the $402.5 million initial public offering of 28,750,000 shares of common stock by Allegro MicroSystems,…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million initial public offering by Biodesix, Inc. The common stock is listed on…